Format

Send to

Choose Destination
See comment in PubMed Commons below
Methods Mol Biol. 2011;764:1-15. doi: 10.1007/978-1-61779-188-8_1.

Therapeutic oligonucleotides.

Author information

1
Department of Chemistry, Worcester State University, Worcester, MA 01602-2597, USA. john.goodchild@worcester.edu

Abstract

A brief historical introduction describes early attempts to silence specific genes using the antisense oligonucleotides that flourished in the 1980s. Early aspirations for therapeutic applications were almost extinguished by the unexpected complexity of oligonucleotide pharmacology. Once the biochemistry and molecular biology behind some of the pharmacology was worked out, new approaches became apparent for using oligonucleotides to treat disease. The biochemistry of small nucleic acids is outlined in Section 2. Various approaches employing oligonucleotides to control cellular functions are reviewed in Section 3. These include antisense oligonucleotides and siRNA that bind to RNA, antigene oligonucleotides that bind to DNA, and aptamers, decoys, and CpG oligonucleotides that bind to proteins.

PMID:
21748630
DOI:
10.1007/978-1-61779-188-8_1
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center